Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Lung Non-Small Cell Cancer AJCC v7”

340 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 340 results

Not applicableStudy completedNCT03798535
What this trial is testing

First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy

Who this might be right for
NSCLC
AstraZeneca 1,156
Early research (Phase 1)UnknownNCT00006212
What this trial is testing

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Center for Molecular Medicine
Testing effectiveness (Phase 2)Study completedNCT00497315
What this trial is testing

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
University Hospital, Antwerp 30
Large-scale testing (Phase 3)Study completedNCT00216125
What this trial is testing

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Nasser Hanna, M.D. 243
Testing effectiveness (Phase 2)Study completedNCT00117962
What this trial is testing

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 109
Not applicableStudy completedNCT06015815
What this trial is testing

The Association of MicroRNA21-155 Levels With Acute Side Effects In Patients With Stage III NSCLC With Definitive CRT

Who this might be right for
Non-small Cell Lung Cancer Stage III
Ankara University 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05015010
What this trial is testing

Alectinib in Neo-adjuvant Treatment of Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 33
Testing effectiveness (Phase 2)Looking for participantsNCT05696782
What this trial is testing

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer Stage IIIUnresectable Non-Small Cell Lung CarcinomaNonsmall Cell Lung Cancer, Stage II
Wake Forest University Health Sciences 28
Testing effectiveness (Phase 2)UnknownNCT04952168
What this trial is testing

Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

Who this might be right for
NSCLC, Stage III
Yuan Chen 26
Testing effectiveness (Phase 2)UnknownNCT04762030
What this trial is testing

Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 39
Testing effectiveness (Phase 2)Ended earlyNCT06003075
What this trial is testing

Induction Chemo-Nivo in Unresectable Stage III NSCLC

Who this might be right for
Lung Cancer, Nonsmall CellLung Cancer Stage III
Ralph G Zinner 1
Large-scale testing (Phase 3)Study completedNCT00020709
What this trial is testing

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 840
Testing effectiveness (Phase 2)Ended earlyNCT00293332
What this trial is testing

Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Lung Cancer
University of California, San Francisco 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT01629498
What this trial is testing

Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7+3 more
M.D. Anderson Cancer Center 146
Testing effectiveness (Phase 2)Looking for participantsNCT06917573
What this trial is testing

PALACE: Cemiplimab Trial According to ctDNA Levels

Who this might be right for
Non Small Cell Lung Cancer MetastaticLung DiseasesStage IV Non-small Cell Lung Cancer+3 more
Fundación GECP 63
Large-scale testing (Phase 3)Active Not RecruitingNCT04092283
What this trial is testing

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+3 more
National Cancer Institute (NCI) 660
Testing effectiveness (Phase 2)WithdrawnNCT00903942
What this trial is testing

Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer, Stage III
University of Rochester
Testing effectiveness (Phase 2)Study completedNCT05386888
What this trial is testing

A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC

Who this might be right for
NSCLC, Stage III
Genfleet Therapeutics (Shanghai) Inc. 65
Not applicableUnknownNCT05027165
What this trial is testing

Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab

Who this might be right for
OncologyBiomarkerNSCLC, Stage III+2 more
LMU Klinikum 40
Not applicableStudy completedNCT04529564
What this trial is testing

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 106
Load More Results